Profile
Christoph Nowak is currently Director at OncoZenge AB starting in 2026 and Chief Medical Officer at Melius Pharma AB. Former positions include Assistant Professor at Karolinska Institutet and Chief Medical & Business Officer at Diamyd Medical AB. Education includes doctorates from the University of Oxford and the University of Uppsala, and undergraduate and graduate degrees from Technische Universität Braunschweig.
Christoph Nowak active positions
| Companies | Position | Start |
|---|---|---|
| ONCOZENGE AB | Director/Board Member | 09/09/2023 |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Develops drug candidates for chronic cough in interstitial lung diseases | Chief Tech/Sci/R&D Officer | - |
Former positions of Christoph Nowak
| Companies | Position | End |
|---|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| DIAMYD MEDICAL AB | Chief Tech/Sci/R&D Officer | - |
Training of Christoph Nowak
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 7 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technische Universität Braunschweig
Technische Universität Braunschweig Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Diamyd Medical AB
Diamyd Medical AB Pharmaceuticals: MajorHealth Technology Develops precision medicine drugs for type 1 diabetes and other forms of autoimmune diabetes | Health Technology |
OncoZenge AB
OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
Melius Pharma AB
Melius Pharma AB Pharmaceuticals: MajorHealth Technology Develops drug candidates for chronic cough in interstitial lung diseases | Health Technology |
- Stock Market
- Insiders
- Christoph Nowak
















